WASHINGTON, June 29, 2017 /PRNewswire-USNewswire/ -- On Thursday, June 22, 2017, Senate Republican leaders released the draft text of the Better Care Reconciliation Act (BCRA), legislation to repeal the Affordable Care Act (ACA). The National Hemophilia Foundation, Hemophilia Federation of America, Coalition for Hemophilia B, and Hemophilia Alliance – which represent people with hemophilia, von Willebrand Disease, and other bleeding disorders and the hemophilia treatment centers (HTCs) that treat them – are united in their opposition to BCRA because of its damaging impact on our community and urge the Senate to reject these harmful policies.
People with hemophilia and other bleeding disorders live with a painful, chronic condition that requires expensive medication and specialized care provided by hemophilia treatment centers (HTCs) and other specialists. Without access to comprehensive insurance, our community members will suffer. We oppose the Senate bill because:
- BCRA will lead to significant coverage losses: With 15 million Americans projected to lose coverage in 2018 under the BCRA, our community is in danger. Repeal of the Medicaid expansion and significant cuts to Medicaid financing will jeopardize coverage for those in our community insured by the program. Lowering income thresholds for tax credits, tying tax credits to less generous coverage, and repealing cost-sharing reduction payments will make coverage out of reach for low- and middle-income Americans.
- People that maintain coverage will pay more for plans that cover less: Premiums, deductibles, and out-of-pocket costs are all expected to rise. In addition, the state waivers of essential health benefits (EHBs) jeopardize access to comprehensive coverage by undermining critical patient protections – such as the ban on lifetime and annual limits – that apply only to EHB services. Pre-existing conditions protections are meaningless if insurance companies can remove services for expensive conditions.
"The Senate must maintain the ban on lifetime and annual limits, which is a life-saving policy for people with bleeding disorders. Allowing states to define the essential health benefits will allow these caps to return, which harms not only our patient community, but other people with acute and chronic medical conditions," said Val Bias, CEO of the National Hemophilia Foundation.
"BCRA's drastic cuts to Medicaid would devastate the most vulnerable members of our community. Its estimated that some 30% of the bleeding disorders community rely on health coverage through Medicaid. BCRA's proposals to phase out the Medicaid expansion, cap federal Medicaid spending, and index future increases to an unreasonably low metric of inflation would be ruinous for people with bleeding disorders and other chronic conditions," added Kimberly Haugstad, President & CEO, Hemophilia Federation of America.
"As the organization that represents hemophilia treatment centers (HTCs), we know how vital comprehensive insurance coverage is to the bleeding disorders community. We don't want any of our patients to lose coverage. We will continue our work with Congress on policies that protect our vulnerable patient population," said Joe Pugliese, President of the Hemophilia Alliance.
This bill will be harmful to not only the bleeding disorders community, but many other vulnerable people living with expensive chronic conditions. Robust and fully-funded state Medicaid programs, Essential Health Benefits that include comprehensive drug coverage, protection from sky-high out of pocket costs, and access to affordable coverage are all vital to our community – and all are threatened by the Senate bill. The bleeding disorders community urges Senators to vote no on the Better Care Reconciliation Act.
About the Organizations:
Hemophilia Federation of America: Hemophilia Federation of America (HFA) is a national 501(c)(3) organization that assists and advocates for the bleeding disorders community. Incorporated in 1994, HFA provides programs and services to improve the quality of life for persons with hemophilia, von Willebrand disease (VWD) and other rare bleeding disorders. Media Contact: Sonji Wilkes, 303-887-2600; [email protected]
National Hemophilia Foundation: The National Hemophilia Foundation (NHF) is dedicated to finding better treatments and cures for inheritable bleeding disorders and to preventing the complications of these disorders through education, advocacy and research. Media Contact: Beth Marshall, 646-530-3598; [email protected]
The Coalition for Hemophilia B: The Coalition for Hemophilia B strives to make quality of life the focal point of treatment for individuals with Hemophilia B in the 21st century. Media Contact: Kim Phelan, 212-520-8272; [email protected]
The Hemophilia Alliance: The Hemophilia Alliance is a non-profit organization comprised of hemophilia treatment centers (HTCs) across the United States that provide patients with hemophilia and other bleeding disorders with comprehensive specialized diagnostic and treatment services and clotting factor delivery programs by participating in the 340B Drug Pricing Program. Media Contact: Joe Pugliese, 215-439-7173; [email protected]
SOURCE Hemophilia Federation of America (HFA)